96 related articles for article (PubMed ID: 8971854)
1. Augmenting of tumor uptake of anti-melanoma antibody MEM136: influence of interferon.
Li J; Merton DA; Duggaraju R; Thakur ML
Nucl Med Biol; 1996 Oct; 23(7):873-9. PubMed ID: 8971854
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-2b immunoconjugate for improving immunoscintigraphy and immunotherapy.
Pallela VR; Rao SP; Thakur ML
J Nucl Med; 2000 Jun; 41(6):1108-13. PubMed ID: 10855643
[TBL] [Abstract][Full Text] [Related]
3. Influence of biological response modifiers: measurement of tumor blood flow and temperature.
Li J; Merton DA; Thakur ML; Barr J; Wilder S; O'Hara MD; Gibbons G; Goldberg B
J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):175-80. PubMed ID: 7834116
[TBL] [Abstract][Full Text] [Related]
4. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
6. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
Murray JL; Zukiwski AA; Mujoo K; Rosenblum MG
J Biol Response Mod; 1990 Dec; 9(6):556-63. PubMed ID: 2074442
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon-alpha-2b on the enhancement of tumour uptake of 99Tcm-labelled monoclonal antibodies.
Li J; Duggaraju R; Maish DR; Thakur ML
Nucl Med Commun; 1996 Apr; 17(4):346-52. PubMed ID: 8786872
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans.
Oriuchi N; Watanabe N; Kanda H; Hashimoto M; Sugiyama S; Takenoshita S; Imai K; Ueda R; Endo K
Cancer Immunol Immunother; 1998 Aug; 46(6):311-7. PubMed ID: 9756415
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
[TBL] [Abstract][Full Text] [Related]
10. Investigations of 99mTc morpholino pretargeting in mice.
Liu G; Liu C; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2003 Jun; 24(6):697-705. PubMed ID: 12766607
[TBL] [Abstract][Full Text] [Related]
11. Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.
Mitchell P; Lee FT; Hall C; Rigopoulos A; Smyth FE; Hekman AM; van Schijndel GM; Powles R; Brechbiel MW; Scott AM
J Nucl Med; 2003 Jul; 44(7):1105-12. PubMed ID: 12843229
[TBL] [Abstract][Full Text] [Related]
12. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
13. Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.
Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
Int J Cancer; 1997 Apr; 71(2):237-45. PubMed ID: 9139849
[TBL] [Abstract][Full Text] [Related]
14. Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotope antibodies.
Chattopadhyay P; Starkey J; Raychaudhuri S
J Immunol; 1991 Sep; 147(6):2055-62. PubMed ID: 1890311
[TBL] [Abstract][Full Text] [Related]
15. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
16. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Gazit Z; Weiss DW; Shouval D; Yechezkeli M; Schirrmacher V; Notter M; Walter J; Kedar E
Cancer Immunol Immunother; 1992; 35(2):135-44. PubMed ID: 1596937
[TBL] [Abstract][Full Text] [Related]
17. Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody.
Ghose T; Ferrone S; Imai K; Norvell ST; Luner SJ; Martin RH; Blair AH
J Natl Cancer Inst; 1982 Oct; 69(4):823-6. PubMed ID: 6956760
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
Sancey L; Ardisson V; Riou LM; Ahmadi M; Marti-Batlle D; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2037-47. PubMed ID: 17674000
[TBL] [Abstract][Full Text] [Related]
20. Effects of a hybrid recombinant human alpha interferon (A/D) on in vitro cytotoxicity and in vivo localization of monoclonal antibody L6-cytosine deaminase conjugate in a colon cancer model.
O'Boyle KP; Senter PD; Bhargava K; Chun S; Anthony G; Markowitz AL; Wadler S
Cancer Biother Radiopharm; 1998 Feb; 13(1):33-42. PubMed ID: 10850340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]